 | • レポートコード：B-GIR08C4802 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ピロチニブの世界市場について調べ、まとめました。種類別セグメントは、160ミリグラムテーブル、80ミリグラムテーブル等、用途別セグメントは、工業用、石油化学、その他等に区分しました。ピロチニブの世界市場概観、企業動向、企業別ピロチニブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ピロチニブの市場概観 ・ピロチニブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ピロチニブの企業別販売動向、市場シェア、市場集中度、競争動向 ・ピロチニブの世界市場規模 ・ピロチニブの北米市場分析（アメリカ、カナダ、メキシコ等） ・ピロチニブのアメリカ市場規模推移 ・ピロチニブのカナダ市場規模推移 ・ピロチニブのメキシコ市場規模推移 ・ピロチニブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ピロチニブのドイツ市場規模推移 ・ピロチニブのイギリス市場規模推移 ・ピロチニブのロシア市場規模推移 ・ピロチニブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ピロチニブの日本市場規模推移 ・ピロチニブの中国市場規模推移 ・ピロチニブの韓国市場規模推移 ・ピロチニブのインド市場規模推移 ・ピロチニブの東南アジア市場規模推移 ・ピロチニブの南米市場分析（ブラジル、アルゼンチン等） ・ピロチニブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ピロチニブの種類別分析/販売量、売上、市場シェア（160ミリグラムテーブル、80ミリグラムテーブル） ・ピロチニブの用途別分析/市場規模（工業用、石油化学、その他） ・ピロチニブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ピロチニブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Pyrotinib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Pyrotinib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Hengrui Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
160mg Tables
80mg Tables
Market Segment by Applications, can be divided into
HER-2+ Advanced Breast Cancer
HER-3+ Metastatic Breast Cancer
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pyrotinib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pyrotinib, with price, sales, revenue and global market share of Pyrotinib in 2017 and 2018.
Chapter 3, the Pyrotinib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pyrotinib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Pyrotinib market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Pyrotinib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Pyrotinib Introduction
1.2 Market Analysis by Type
1.2.1 160mg Tables
1.2.2 80mg Tables
1.3 Market Analysis by Applications
1.3.1 HER-2+ Advanced Breast Cancer
1.3.2 HER-3+ Metastatic Breast Cancer
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Hengrui Pharmaceutical
2.1.1 Business Overview
2.1.2 Pyrotinib Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Hengrui Pharmaceutical Pyrotinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Pyrotinib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Pyrotinib Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Pyrotinib Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Pyrotinib Manufacturer Market Share in 2018
3.3.2 Top 6 Pyrotinib Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Pyrotinib Market Analysis by Regions
4.1 Global Pyrotinib Sales, Revenue and Market Share by Regions
4.1.1 Global Pyrotinib Sales and Market Share by Regions (2014-2019)
4.1.2 Global Pyrotinib Revenue and Market Share by Regions (2014-2019)
4.2 North America Pyrotinib Sales and Growth Rate (2014-2019)
4.3 Europe Pyrotinib Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Pyrotinib Sales and Growth Rate (2014-2019)
4.5 South America Pyrotinib Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Pyrotinib Sales and Growth Rate (2014-2019)
5 North America Pyrotinib by Country
5.1 North America Pyrotinib Sales, Revenue and Market Share by Country
5.1.1 North America Pyrotinib Sales and Market Share by Country (2014-2019)
5.1.2 North America Pyrotinib Revenue and Market Share by Country (2014-2019)
5.2 United States Pyrotinib Sales and Growth Rate (2014-2019)
5.3 Canada Pyrotinib Sales and Growth Rate (2014-2019)
5.4 Mexico Pyrotinib Sales and Growth Rate (2014-2019)
6 Europe Pyrotinib by Country
6.1 Europe Pyrotinib Sales, Revenue and Market Share by Country
6.1.1 Europe Pyrotinib Sales and Market Share by Country (2014-2019)
6.1.2 Europe Pyrotinib Revenue and Market Share by Country (2014-2019)
6.2 Germany Pyrotinib Sales and Growth Rate (2014-2019)
6.3 UK Pyrotinib Sales and Growth Rate (2014-2019)
6.4 France Pyrotinib Sales and Growth Rate (2014-2019)
6.5 Russia Pyrotinib Sales and Growth Rate (2014-2019)
6.6 Italy Pyrotinib Sales and Growth Rate (2014-2019)
7 Asia-Pacific Pyrotinib by Country
7.1 Asia-Pacific Pyrotinib Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Pyrotinib Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Pyrotinib Revenue and Market Share by Country (2014-2019)
7.2 China Pyrotinib Sales and Growth Rate (2014-2019)
7.3 Japan Pyrotinib Sales and Growth Rate (2014-2019)
7.4 Korea Pyrotinib Sales and Growth Rate (2014-2019)
7.5 India Pyrotinib Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Pyrotinib Sales and Growth Rate (2014-2019)
8 South America Pyrotinib by Country
8.1 South America Pyrotinib Sales, Revenue and Market Share by Country
8.1.1 South America Pyrotinib Sales and Market Share by Country (2014-2019)
8.1.2 South America Pyrotinib Revenue and Market Share by Country (2014-2019)
8.2 Brazil Pyrotinib Sales and Growth Rate (2014-2019)
8.3 Argentina Pyrotinib Sales and Growth Rate (2014-2019)
8.4 Colombia Pyrotinib Sales and Growth Rate (2014-2019)
9 Middle East and Africa Pyrotinib by Countries
9.1 Middle East and Africa Pyrotinib Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Pyrotinib Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Pyrotinib Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Pyrotinib Sales and Growth Rate (2014-2019)
9.3 Turkey Pyrotinib Sales and Growth Rate (2014-2019)
9.4 Egypt Pyrotinib Sales and Growth Rate (2014-2019)
9.5 Nigeria Pyrotinib Sales and Growth Rate (2014-2019)
9.6 South Africa Pyrotinib Sales and Growth Rate (2014-2019)
10 Global Pyrotinib Market Segment by Type
10.1 Global Pyrotinib Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Pyrotinib Sales and Market Share by Type (2014-2019)
10.1.2 Global Pyrotinib Revenue and Market Share by Type (2014-2019)
10.2 160mg Tables Sales Growth and Price
10.2.1 Global 160mg Tables Sales Growth (2014-2019)
10.2.2 Global 160mg Tables Price (2014-2019)
10.3 80mg Tables Sales Growth and Price
10.3.1 Global 80mg Tables Sales Growth (2014-2019)
10.3.2 Global 80mg Tables Price (2014-2019)
11 Global Pyrotinib Market Segment by Application
11.1 Global Pyrotinib Sales Market Share by Application (2014-2019)
11.2 HER-2+ Advanced Breast Cancer Sales Growth (2014-2019)
11.3 HER-3+ Metastatic Breast Cancer Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Pyrotinib Market Forecast (2019-2024)
12.1 Global Pyrotinib Sales, Revenue and Growth Rate (2019-2024)
12.2 Pyrotinib Market Forecast by Regions (2019-2024)
12.2.1 North America Pyrotinib Market Forecast (2019-2024)
12.2.2 Europe Pyrotinib Market Forecast (2019-2024)
12.2.3 Asia-Pacific Pyrotinib Market Forecast (2019-2024)
12.2.4 South America Pyrotinib Market Forecast (2019-2024)
12.2.5 Middle East and Africa Pyrotinib Market Forecast (2019-2024)
12.3 Pyrotinib Market Forecast by Type (2019-2024)
12.3.1 Global Pyrotinib Sales Forecast by Type (2019-2024)
12.3.2 Global Pyrotinib Market Share Forecast by Type (2019-2024)
12.4 Pyrotinib Market Forecast by Application (2019-2024)
12.4.1 Global Pyrotinib Sales Forecast by Application (2019-2024)
12.4.2 Global Pyrotinib Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Pyrotinib Picture
Table Product Specifications of Pyrotinib
Figure Global Sales Market Share of Pyrotinib by Types in 2018
Table Pyrotinib Types for Major Manufacturers
Figure 160mg Tables Picture
Figure 80mg Tables Picture
Figure Pyrotinib Sales Market Share by Applications in 2018
Figure HER-2+ Advanced Breast Cancer Picture
Figure HER-3+ Metastatic Breast Cancer Picture
Figure Other Picture
Figure United States Pyrotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Pyrotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Pyrotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Pyrotinib Revenue (Value) and Growth Rate (2014-2024)
Figure France Pyrotinib Revenue (Value) and Growth Rate (2014-2024)
Figure UK Pyrotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Pyrotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Pyrotinib Revenue (Value) and Growth Rate (2014-2024)
Figure China Pyrotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Pyrotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Pyrotinib Revenue (Value) and Growth Rate (2014-2024)
Figure India Pyrotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Pyrotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Pyrotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Pyrotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Pyrotinib Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Pyrotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Pyrotinib Revenue (Value) and Growth Rate (2014-2024)
Table Hengrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Hengrui Pharmaceutical Pyrotinib Type and Applications
Table Hengrui Pharmaceutical Pyrotinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Pyrotinib Sales by Manufacturer (2017-2018)
Figure Global Pyrotinib Sales Market Share by Manufacturer in 2017
Figure Global Pyrotinib Sales Market Share by Manufacturer in 2018
Table Global Pyrotinib Revenue by Manufacturer (2017-2018)
Figure Global Pyrotinib Revenue Market Share by Manufacturer in 2017
Figure Global Pyrotinib Revenue Market Share by Manufacturer in 2018
Figure Top 3 Pyrotinib Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Pyrotinib Manufacturer (Revenue) Market Share in 2018
Figure Global Pyrotinib Sales and Growth Rate (2014-2019)
Figure Global Pyrotinib Revenue and Growth Rate (2014-2019)
Table Global Pyrotinib Sales by Regions (2014-2019)
Table Global Pyrotinib Sales Market Share by Regions (2014-2019)
Table Global Pyrotinib Revenue by Regions (2014-2019)
Figure Global Pyrotinib Revenue Market Share by Regions (2014-2019)
Figure Global Pyrotinib Revenue Market Share by Regions in 2018
Figure North America Pyrotinib Sales and Growth Rate (2014-2019)
Figure Europe Pyrotinib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Pyrotinib Sales and Growth Rate (2014-2019)
Figure South America Pyrotinib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Pyrotinib Sales and Growth Rate (2014-2019)
Figure North America Pyrotinib Revenue and Growth Rate (2014-2019)
Table North America Pyrotinib Sales by Countries (2014-2019)
Table North America Pyrotinib Sales Market Share by Countries (2014-2019)
Figure North America Pyrotinib Sales Market Share by Countries (2014-2019)
Figure North America Pyrotinib Sales Market Share by Countries in 2018
Table North America Pyrotinib Revenue by Countries (2014-2019)
Table North America Pyrotinib Revenue Market Share by Countries (2014-2019)
Figure North America Pyrotinib Revenue Market Share by Countries (2014-2019)
Figure North America Pyrotinib Revenue Market Share by Countries in 2018
Figure United States Pyrotinib Sales and Growth Rate (2014-2019)
Figure Canada Pyrotinib Sales and Growth Rate (2014-2019)
Figure Mexico Pyrotinib Sales and Growth Rate (2014-2019)
Figure Europe Pyrotinib Revenue and Growth Rate (2014-2019)
Table Europe Pyrotinib Sales by Countries (2014-2019)
Table Europe Pyrotinib Sales Market Share by Countries (2014-2019)
Table Europe Pyrotinib Revenue by Countries (2014-2019)
Figure Europe Pyrotinib Revenue Market Share by Countries (2014-2019)
Figure Europe Pyrotinib Revenue Market Share by Countries in 2018
Figure Germany Pyrotinib Sales and Growth Rate (2014-2019)
Figure UK Pyrotinib Sales and Growth Rate (2014-2019)
Figure France Pyrotinib Sales and Growth Rate (2014-2019)
Figure Russia Pyrotinib Sales and Growth Rate (2014-2019)
Figure Italy Pyrotinib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Pyrotinib Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Pyrotinib Sales by Countries (2014-2019)
Table Asia-Pacific Pyrotinib Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Pyrotinib Sales Market Share by Countries 2018
Table Asia-Pacific Pyrotinib Revenue by Countries (2014-2019)
Figure Asia-Pacific Pyrotinib Revenue Market Share by Countries 2018
Figure China Pyrotinib Sales and Growth Rate (2014-2019)
Figure Japan Pyrotinib Sales and Growth Rate (2014-2019)
Figure Korea Pyrotinib Sales and Growth Rate (2014-2019)
Figure India Pyrotinib Sales and Growth Rate (2014-2019)
Figure Southeast Asia Pyrotinib Sales and Growth Rate (2014-2019)
Figure South America Pyrotinib Revenue and Growth Rate (2014-2019)
Table South America Pyrotinib Sales by Countries (2014-2019)
Table South America Pyrotinib Sales Market Share by Countries (2014-2019)
Figure South America Pyrotinib Sales Market Share by Countries in 2018
Table South America Pyrotinib Revenue by Countries (2014-2019)
Table South America Pyrotinib Revenue Market Share by Countries (2014-2019)
Figure South America Pyrotinib Revenue Market Share by Countries in 2018
Figure Brazil Pyrotinib Sales and Growth Rate (2014-2019)
Figure Argentina Pyrotinib Sales and Growth Rate (2014-2019)
Figure Colombia Pyrotinib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Pyrotinib Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Pyrotinib Sales by Countries (2014-2019)
Table Middle East and Africa Pyrotinib Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Pyrotinib Sales Market Share by Countries in 2018
Table Middle East and Africa Pyrotinib Revenue by Countries (2014-2019)
Table Middle East and Africa Pyrotinib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Pyrotinib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Pyrotinib Revenue Market Share by Countries in 2018
Figure Saudi Arabia Pyrotinib Sales and Growth Rate (2014-2019)
Figure UAE Pyrotinib Sales and Growth Rate (2014-2019)
Figure Egypt Pyrotinib Sales and Growth Rate (2014-2019)
Figure Nigeria Pyrotinib Sales and Growth Rate (2014-2019)
Figure South Africa Pyrotinib Sales and Growth Rate (2014-2019)
Table Global Pyrotinib Sales by Type (2014-2019)
Table Global Pyrotinib Sales Share by Type (2014-2019)
Table Global Pyrotinib Revenue by Type (2014-2019)
Table Global Pyrotinib Revenue Share by Type (2014-2019)
Figure Global 160mg Tables Sales Growth (2014-2019)
Figure Global 160mg Tables Price (2014-2019)
Figure Global 80mg Tables Sales Growth (2014-2019)
Figure Global 80mg Tables Price (2014-2019)
Table Global Pyrotinib Sales by Application (2014-2019)
Table Global Pyrotinib Sales Share by Application (2014-2019)
Figure Global HER-3+ Metastatic Breast Cancer Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Pyrotinib Sales, Revenue and Growth Rate (2019-2024)
Table Global Pyrotinib Sales Forecast by Regions (2019-2024)
Table Global Pyrotinib Market Share Forecast by Regions (2019-2024)
Figure North America Sales Pyrotinib Market Forecast (2019-2024)
Figure Europe Sales Pyrotinib Market Forecast (2019-2024)
Figure Asia-Pacific Sales Pyrotinib Market Forecast (2019-2024)
Figure South America Sales Pyrotinib Market Forecast (2019-2024)
Figure Middle East and Africa Sales Pyrotinib Market Forecast (2019-2024)
Table Global Pyrotinib Sales Forecast by Type (2019-2024)
Table Global Pyrotinib Market Share Forecast by Type (2019-2024)
Table Global Pyrotinib Sales Forecast by Application (2019-2024)
Table Global Pyrotinib Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界の転移性乳がんの治療市場：市場規模・現状・予測 Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…- 乳癌用HER-2標的薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global HER-2 Targeted Drugs for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especia…
- 乳がんPARP阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global PARP Inhibitors for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially i…
- 乳がんCDK4 / 6阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global CDK4/6 Inhibitors for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially…
- 乳がん用アロマターゼ阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Aromatase Inhibitors for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especia…